Physicochemical/structural investigation of lipid nanoparticles with high lecithin amounts loaded with patent protected pyrazoloquinolinone ligand DK-I-60-3
Authors
Mitrović, Jelena
Petković, Miloš

Ranđelović, Danijela

Đoković, Jelena

Knutson, Daniel

Cook, James

Savić, Vladimir

Savić, Miroslav

Savić, Snežana

Conference object (Published version)
Metadata
Show full item recordAbstract
Lipid nanoparticles are being intensively investigated for
the formulation of the drugs with poor solubility substances
(1). They represent colloid dispersions of the particles with
lipid matrix that is solid at room and body temperature.
Because of the low capacity of triglycerides for the drug
substances incorporation, alternatively, high amounts of
lecithin could be added to increase the solubilization (2).
This was used for the incorporation of DK-I-60-3 (7-
methoxy-d3-2-(4-methoxyd3-phenyl)-2,5-dihydro-
3Hpyrazolo[4,3-c]quinolin-3-one), novel deuterated
pyrazoloquinolinone ligand, with very low solubility in
water as well as in oils (3,4). However, because of
amphiphilic nature of lecithin, its localization within
nanoparticles should be analyzed, especially with respect
to stability, drug loading capacity and drug localization,
because it may additionally influence the drug release
mechanism (2).
Keywords:
pyrazoloquinolinone ligand DK-I-60-3 / Physicochemical/structural investigation / lipid nanoparticlesSource:
13th World meeting on pharmaceutics, biopharmaceutics and pharmaceutical technology, 28-31 March 2022, Rotterdam, Netherlands, 2022Funding / projects:
- NanoCellEmoCog - Neuroimmune aspects of mood, anxiety and cognitive effects of leads/drug candidates acting at GABAA and/or sigma-2 receptors: In vitro/in vivo delineation by nano- and hiPSC-based platform (RS-7749108)
- Ministry of Education, Science and Technological Development, Republic of Serbia, Grant no. 200161 (University of Belgrade, Faculty of Pharmacy) (RS-200161)
Institution/Community
PharmacyTY - CONF AU - Mitrović, Jelena AU - Petković, Miloš AU - Ranđelović, Danijela AU - Đoković, Jelena AU - Knutson, Daniel AU - Cook, James AU - Savić, Vladimir AU - Savić, Miroslav AU - Savić, Snežana PY - 2022 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4097 AB - Lipid nanoparticles are being intensively investigated for the formulation of the drugs with poor solubility substances (1). They represent colloid dispersions of the particles with lipid matrix that is solid at room and body temperature. Because of the low capacity of triglycerides for the drug substances incorporation, alternatively, high amounts of lecithin could be added to increase the solubilization (2). This was used for the incorporation of DK-I-60-3 (7- methoxy-d3-2-(4-methoxyd3-phenyl)-2,5-dihydro- 3Hpyrazolo[4,3-c]quinolin-3-one), novel deuterated pyrazoloquinolinone ligand, with very low solubility in water as well as in oils (3,4). However, because of amphiphilic nature of lecithin, its localization within nanoparticles should be analyzed, especially with respect to stability, drug loading capacity and drug localization, because it may additionally influence the drug release mechanism (2). C3 - 13th World meeting on pharmaceutics, biopharmaceutics and pharmaceutical technology, 28-31 March 2022, Rotterdam, Netherlands T1 - Physicochemical/structural investigation of lipid nanoparticles with high lecithin amounts loaded with patent protected pyrazoloquinolinone ligand DK-I-60-3 UR - https://hdl.handle.net/21.15107/rcub_farfar_4097 ER -
@conference{ author = "Mitrović, Jelena and Petković, Miloš and Ranđelović, Danijela and Đoković, Jelena and Knutson, Daniel and Cook, James and Savić, Vladimir and Savić, Miroslav and Savić, Snežana", year = "2022", abstract = "Lipid nanoparticles are being intensively investigated for the formulation of the drugs with poor solubility substances (1). They represent colloid dispersions of the particles with lipid matrix that is solid at room and body temperature. Because of the low capacity of triglycerides for the drug substances incorporation, alternatively, high amounts of lecithin could be added to increase the solubilization (2). This was used for the incorporation of DK-I-60-3 (7- methoxy-d3-2-(4-methoxyd3-phenyl)-2,5-dihydro- 3Hpyrazolo[4,3-c]quinolin-3-one), novel deuterated pyrazoloquinolinone ligand, with very low solubility in water as well as in oils (3,4). However, because of amphiphilic nature of lecithin, its localization within nanoparticles should be analyzed, especially with respect to stability, drug loading capacity and drug localization, because it may additionally influence the drug release mechanism (2).", journal = "13th World meeting on pharmaceutics, biopharmaceutics and pharmaceutical technology, 28-31 March 2022, Rotterdam, Netherlands", title = "Physicochemical/structural investigation of lipid nanoparticles with high lecithin amounts loaded with patent protected pyrazoloquinolinone ligand DK-I-60-3", url = "https://hdl.handle.net/21.15107/rcub_farfar_4097" }
Mitrović, J., Petković, M., Ranđelović, D., Đoković, J., Knutson, D., Cook, J., Savić, V., Savić, M.,& Savić, S.. (2022). Physicochemical/structural investigation of lipid nanoparticles with high lecithin amounts loaded with patent protected pyrazoloquinolinone ligand DK-I-60-3. in 13th World meeting on pharmaceutics, biopharmaceutics and pharmaceutical technology, 28-31 March 2022, Rotterdam, Netherlands. https://hdl.handle.net/21.15107/rcub_farfar_4097
Mitrović J, Petković M, Ranđelović D, Đoković J, Knutson D, Cook J, Savić V, Savić M, Savić S. Physicochemical/structural investigation of lipid nanoparticles with high lecithin amounts loaded with patent protected pyrazoloquinolinone ligand DK-I-60-3. in 13th World meeting on pharmaceutics, biopharmaceutics and pharmaceutical technology, 28-31 March 2022, Rotterdam, Netherlands. 2022;. https://hdl.handle.net/21.15107/rcub_farfar_4097 .
Mitrović, Jelena, Petković, Miloš, Ranđelović, Danijela, Đoković, Jelena, Knutson, Daniel, Cook, James, Savić, Vladimir, Savić, Miroslav, Savić, Snežana, "Physicochemical/structural investigation of lipid nanoparticles with high lecithin amounts loaded with patent protected pyrazoloquinolinone ligand DK-I-60-3" in 13th World meeting on pharmaceutics, biopharmaceutics and pharmaceutical technology, 28-31 March 2022, Rotterdam, Netherlands (2022), https://hdl.handle.net/21.15107/rcub_farfar_4097 .